FULC vs NWS
Fulcrum Therapeutics Inc (FULC) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
NWS (NWS) common stock.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
NWS does not have a complete income-statement cache yet.
FULC currently screens at market cap $427.0M. NWS currently screens at market cap $0.
Not investment advice. Open the FULC and NWS stock pages for the full models.
Not investment advice.